WHO Guideline on GLP-1 Therapies for Obesity in Adults

This Special Communication summarizes the WHO guideline on the management of obesity with GLP-1 therapies in adults and calls on nations to ensure equitable access to obesity prevention and management interventions.

WHO warning over shortage of obesity jabs – BBC

WHO warning over shortage of obesity jabs  BBC WHO recommends GLP-1 drugs for obesity  NBC News World Health Organization issues first-ever guidelines for use of GLP-1 weight loss medications  ABC News WHO says weight loss drugs are ‘new chapter’ in fight against obesity  The Guardian World Health Organization recommends GLP-1s for obesity. There’s a catch.  USA Today

WHO backs GLP-1 treatments to tackle obesity epidemic

The World Health Organization has unveiled new recommendations indicating that revolutionary weight-loss drugs could play a vital role in addressing the escalating obesity epidemic. Specifically, GLP-1 agonist therapies are suggested for long-term obesity care in adults.

WHO conditionally recommends GLP-1 drugs for obesity

The first conditional recommendation by the organization advises the use of GLP-1 drugs by adults, except pregnant women, for long-term obesity treatment, while the second suggests interventions like a healthy diet and physical activity to be offered alongside the medicines.

Why the Marks & Spencer share price fell 14% in November

November proved to be a tough month for the Marks & Spencer (LSE:MKS) share price. It was one of the worst-performing stocks in the FTSE 100, falling almost 14% in the month. Here’s what caused the move and where I think it could go from here. Key factors to note In April 2025, the business […]